Apellis Pharmaceuticals Earning Date (APLS)

USA |NASDAQ |USD

APLS Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 8, 2022 Jun 2022 $-1.31 - $-2.72
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 8, 2022 Jun 2022 $24.58M - $623.00K

Apellis Pharmaceuticals's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 2022.

APLS Earnings Date & History Chart

APLS Earnings & Revenue Forecast

APLS Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 14 $-1.31 $-1.91 $-0.68
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 14 $-5.33 $-7.29 $-3.94
Dec 2023 13 $-4.06 $-6.57 $-1.82

APLS Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 2 / 1 $-1.33 $-1.33 $-1.29
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 3 / 1 $-5.35 $-5.35 $-5.38
Dec 2023 1 / 1 $-3.70 $-3.57 $-3.48

APLS Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Jun 2022 13 $24.58M $14.73M $66.00M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 15 $96.77M $63.36M $169.40M
Dec 2023 13 $274.95M $172.39M $481.06M

APLS Earnings Date & Revenue History

APLS Earnings History

|
Show More
Show More

APLS Revenue History

|
Show More
Show More

Apellis Pharmaceuticals Next Earnings Date & Report

APLS Next Earnings Date & Report Preview: Jun 2022 (FQ)

APLS's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 30, 2022.

According to analysts, the average EPS estimation for Apellis Pharmaceuticals's next quarterly earnings is $-1.31, with a low EPS estimation of $-1.91, and a high estimation of $-0.68.

Over the last 1 month, EPS estimates have seen 2 upward revisions and 1 downward. The EPS 1 month trend is $-1.33, the last 2 month trend is $-1.33, and the 3 month trend is $-1.29.

Based on analysts, the average revenue estimation is $24.58M, with a low revenue estimation of $14.73M, and a high estimation of $66.00M.

Apellis Pharmaceuticals Previous Earnings Dates & Reports

APLS Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Apellis Pharmaceuticals's previous earnings date was May 4, 2022 for its fiscal quarter ended Mar 31, 2022.

APLS Previous Earnings Date & Report Recap: Dec 2021 (FY)

Apellis Pharmaceuticals's previous annual earnings date was Feb 28, 2022 for its fiscal year ended Dec 31, 2021.

APLS's earnings per share (EPS) was $-8.93, missing the consensus analysts forecast of $-8.77 by 1.82% , and lower than the previous year's EPS (Dec 2020) by 89.19%.

Revenues were $66.56M, better than the forecast of $15.02M by 343.16%, and down by -73.44% from previous year's revenue.

The company reported a net income of $-746.35M.

Apellis Pharmaceuticals reported a free cash flow of $-564.23M for its fiscal year, compared to $-165.91M a year ago.

The company ended the fiscal year with $210.22M in total debt, a decrease of -42.01% compared to the previous year.